Higher NAb levels provided protection against illness and transmission in study models.
New findings from a Cleveland Clinic-led study upend conventional wisdom about the long-term outcomes of ACL surgery.
What do the phase 3 trials of COVID-19 vaccine candidates mean for the general population and healthcare workers battling the virus on the frontlines? In this article, immunologist Thaddeus Stappenbeck, MD, PhD, puts the trial results into context.
A potential novel therapeutic strategy in rhabdomyosarcoma, a new study finds. In this article, Neetu Gupta, PhD, director of the Center of Excellence in Lymphoid Malignancies Research explains her findings.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
A new network medicine study finds that melatonin usage may prevent COVID-19 infection, though large-scale trials are needed. Researcher Feixiong Cheng, PhD, discusses his team’s findings.
A new study led by researchers from Cleveland Clinic reports that receiving the influenza vaccine does not increase a person’s risk for contracting COVID-19 or worsen associated morbidity or mortality. Joe Zein, MD, a practicing pulmonologist in the Respiratory Institute, shares insights from the study.
A pacuity of models hinders the development of treatments for Ewing sarcoma, a common and deadly pediatric cancer involving bone and soft tissues. To remedy this, researchers are creating zebrafish models that will enable the study of the biology of Ewing sarcoma.
Traditional methods of drug discovery cannot keep up with the rapid emergence and mutation of human coronavirus epidemics. Feixiong Cheng, PhD, has applied a network-based prediction model to identify targets for drug repurposing for the treatment of COVID-19.
With grant funding from the Department of Defense, a team of researchers will test the ability of a new machine learning algorithm to accurately determine the degree of stenosis and predict the precise plaque composition. Dr. Geoffrey Vince discusses the project, which he believes could lead to a new means of clinically assessing stroke risk.
Targeting the microbe-host adhesion process may lead to a new class of antimicrobial drugs. Jeannette Messer, DVM, PhD, discusses her efforts to develop small molecules that can help treat or prevent a wide range of microbial-related infectious diseases.